| Josie Hughes, RN | |
|
2410 Jefferson Ave, Point Pleasant, WV 25550-1528 | |
| (304) 675-7400 | |
| (304) 675-7401 |
| Full Name | Josie Hughes |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 2410 Jefferson Ave, Point Pleasant, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194448712 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 83688 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Josie Hughes, RN 2410 Jefferson Ave, Point Pleasant, WV 25550-1528 Ph: (304) 675-7400 | Josie Hughes, RN 2410 Jefferson Ave, Point Pleasant, WV 25550-1528 Ph: (304) 675-7400 |
News Archive
Brown University researchers have found that there are multiple independent ways to stop cell division, a phenomenon that prevents the spread of genetic mutation, which can make cells cancerous. Results of this research, along with an accompanying editorial, were published in the current issue of the journal Molecular Cell.
Afatinib (trade name: Giotrif) has been approved since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).
A new study of medical staff treating COVID-19-infected patients found 42.8% experienced serious skin injury related to the use of personal protective equipment, including masks, goggles, face shields, and protective gowns.
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
› Verified 1 days ago
Lori Zerkle, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Pleasant Valley Home Health - Point Pleasant, 2410 Jefferson Avenue, Point Pleasant, WV 25550 Phone: 304-675-7400 | |
Miss Myra Lynnette Schultz, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2410 Jefferson Ave, Point Pleasant, WV 25550 Phone: 304-675-7400 | |
Ruth Upton, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 2nd St, Point Pleasant, WV 25550 Phone: 304-675-2369 | |
Kelly Ann Beaver, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2401 Jefferson Ave, Point Pleasant, WV 25550 Phone: 304-675-7400 | |
Lydia C. Gordon, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1200 Main St, Point Pleasant, WV 25550 Phone: 304-675-4540 | |
Mrs. Lori D. Arbogast, MSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1794 Letart Rd, Point Pleasant, WV 25550 Phone: 304-593-2068 |